Format

Send to

Choose Destination

See 1 citation found by title matching your search:

Oncotarget. 2015 Nov 3;6(34):35218-30. doi: 10.18632/oncotarget.6143.

Chromosome transplantation as a novel approach for correcting complex genomic disorders.

Author information

1
Milan Unit, Istituto di Ricerca Genetica e Biomedica, CNR, Milan, Italy.
2
Humanitas Clinical and Research Center, Rozzano, Milan, Italy.
3
Centro Ricerche Biotecnologiche, Università Cattolica del Sacro Cuore, Cremona, Italy.
4
Avantea, Cremona, Italy.
5
Mouse and Animal Pathology Laboratory, Fondazione Filarete, Milan, Italy.
6
CRS4 Bioinformatics Laboratory, Parco Scientifico e Tecnologico POLARIS, Pula, Cagliari, Italy.
7
Department of Veterinary Sciences and Public Health, University of Milan, Milan, Italy.
8
Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.

Abstract

Genomic disorders resulting from large rearrangements of the genome remain an important unsolved issue in gene therapy. Chromosome transplantation, defined as the perfect replacement of an endogenous chromosome with a homologous one, has the potential of curing this kind of disorders. Here we report the first successful case of chromosome transplantation by replacement of an endogenous X chromosome carrying a mutation in the Hprt genewith a normal one in mouse embryonic stem cells (ESCs), correcting the genetic defect. The defect was also corrected by replacing the Y chromosome with an X chromosome. Chromosome transplanted clones maintained in vitro and in vivo features of stemness and contributed to chimera formation. Genome integrity was confirmed by cytogenetic and molecular genome analysis. The approach here proposed, with some modifications, might be used to cure various disorders due to other X chromosome aberrations in induced pluripotent stem (iPS) cells derived from affected patients.

KEYWORDS:

cell therapy; chromosome transplantation; embryonic stem cells; genomic disorders; microcell fusion

PMID:
26485770
PMCID:
PMC4742100
DOI:
10.18632/oncotarget.6143
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center